Saturday, October 11, 2008 - 7:05AM EST

Drug Therapy

1. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.

Author
Vohora D;
Institution
Jamia Hamdard (Hamdard University), Faculty of Pharmacy, Department of Pharmacology, New Delhi 110062, India. divyavohora@hotmail.com
Journal
Curr Opin Investig Drugs. 2007 Jul;8(7):531-8.
Abstract URL
Click here to view abstract

2. The attitude of patients towards antipsychotic depot treatment.

Author
Heres S; Schmitz FS; Leucht S; Pajonk FG;
Institution
aKlinik und Poliklinik fuer Psychiatrie und Psychotherapie, Technical University Munich bDepartment of Psychiatry and Psychotherapy, The Saarland University Hospitals, Homburg/Saar.
Journal
Int Clin Psychopharmacol. 2007 Sep;22(5):275-82.
Abstract URL
Click here to view abstract

3. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.

Author
Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC; Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC;
Institution
Schizophrenia Research Center, Neuropsychiatry Section, University of Pennsylvania, Philadelphia, PA, USA.
Journal
Cognit Neuropsychiatry. 2007 Sep;12(5):412-21.
Abstract URL
Click here to view abstract

4. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.

Author
Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
Institution
University of Hull, Hull, UK.
Journal
Hum Psychopharmacol. 2007 Aug 9;.
Abstract URL
Click here to view abstract

5. Novel targets for drugs in schizophrenia.

Author
Stone JM; Pilowsky LS;
Institution
Section of Neurochemical Imaging, Kings College London Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK. j.stone@iop.kcl.ac.uk.
Journal
CNS Neurol Disord Drug Targets. 2007 Aug;6(4):265-72.
Abstract URL
Click here to view abstract

6. Clozapine-induced hypersalivation: a review of treatment strategies.

Author
Sockalingam S; Shammi C; Remington G;
Institution
Department of Psychiatry, University of Toronto, Ontario. Sanjeev_Sockalingam@camh.net
Journal
Can J Psychiatry. 2007 Jun;52(6):377-84.
Abstract URL
Click here to view abstract

7. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?-A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.

Author
Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H;
Institution
Department of Neuro-Psychiatry, School of Medicine, Keio University, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan, takefumi@oak.dti.ne.jp.
Journal
Psychopharmacology (Berl). 2007 Aug 14;.
Abstract URL
Click here to view abstract

8. Outcome following clozapine discontinuation: a retrospective analysis.

Author
Atkinson JM; Douglas-Hall P; Fischetti C; Sparshatt A; Taylor DM;
Institution
South London and Maudsley National Health Service (NHS) Trust, Pharmacy Department, Maudsley Hospital, London, United Kingdom. jamesatkinson@nhs.net
Journal
J Clin Psychiatry. 2007 Jul;68(7):1027-30.
Abstract URL
Click here to view abstract

9. Monitored Naltrexone without Counseling for Alcohol Abuse/Dependence in Schizophrenia-Spectrum Disorders.

Author
Batki SL; Dimmock JA; Wade M; Gately PW; Cornell M; Maisto SA; Carey KB; Ploutz-Snyder R;
Institution
Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York.
Journal
Am J Addict. 2007 Jul-Aug;16(4):253-9.
Abstract URL
Click here to view abstract

10. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

Author
Akerele E; Levin FR;
Institution
Department of Psychiatry, Harlem Hospital, College of Physicians and Surgeons of Columbia University, New York, New York.
Journal
Am J Addict. 2007 Jul-Aug;16(4):260-8.
Abstract URL
Click here to view abstract
Pages: 1 2 3


Previous Section
Next Section